ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,603 | +206.3% | 3,610 | -21.7% | 0.00% | +100.0% |
| Q2 2023 | $1,503 | -42.5% | 4,610 | -24.1% | 0.00% | 0.0% |
| Q1 2023 | $2,612 | -18.9% | 6,075 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,220 | -19.5% | 6,075 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | -42.9% | 6,075 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $7,000 | -41.7% | 6,075 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $12,000 | -29.4% | 6,075 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $17,000 | +1600.0% | 6,075 | +5422.7% | 0.01% | +700.0% |
| Q3 2021 | $1,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,000 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |